Advertisement

Topics

Heptares agrees to purchase G7 for $11.8M

04:25 EST 1 Dec 2016 | SmartBrief

G7 Therapeutics will be purchased by Heptares Therapeutics for $11.8 million, become a wholly owned subsidiary of the firm an -More

Original Article: Heptares agrees to purchase G7 for $11.8M

NEXT ARTICLE

More From BioPortfolio on "Heptares agrees to purchase G7 for $11.8M"

Quick Search
Advertisement